Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

  • Filters activated: AIDS. Clear all to show 2490 items.
1.

Effects of antiretroviral treatment on paraoxonase 1 (PON1) activity in rats.

Pastryk JE, Rusek M, Bełtowski J.

Chem Biol Interact. 2016 Nov 25;259(Pt B):407-412. doi: 10.1016/j.cbi.2016.06.031. Epub 2016 Jul 1.

PMID:
27378623
2.

A novel expression cassette delivers efficient production of exclusively tetrameric human butyrylcholinesterase with improved pharmacokinetics for protection against organophosphate poisoning.

Terekhov S, Smirnov I, Bobik T, Shamborant O, Zenkova M, Chernolovskaya E, Gladkikh D, Murashev A, Dyachenko I, Palikov V, Palikova Y, Knorre V, Belogurov A Jr, Ponomarenko N, Blackburn GM, Masson P, Gabibov A.

Biochimie. 2015 Nov;118:51-9. doi: 10.1016/j.biochi.2015.07.028. Epub 2015 Aug 1.

PMID:
26239905
3.

Oxidative stress resulting from exposure of a human salivary gland cells to paraoxon: an in vitro model for organophosphate oral exposure.

Prins JM, Chao CK, Jacobson SM, Thompson CM, George KM.

Toxicol In Vitro. 2014 Aug;28(5):715-21. doi: 10.1016/j.tiv.2014.01.009. Epub 2014 Jan 29.

4.

Forskolin and derivatives as tools for studying the role of cAMP.

Alasbahi RH, Melzig MF.

Pharmazie. 2012 Jan;67(1):5-13. Review.

PMID:
22393824
5.

Immunomodulation by poly-YE reduces organophosphate-induced brain damage.

Finkelstein A, Kunis G, Berkutzki T, Ronen A, Krivoy A, Yoles E, Last D, Mardor Y, Van Shura K, McFarland E, Capacio BA, Eisner C, Gonzales M, Gregorowicz D, Eisenkraft A, McDonough JH, Schwartz M.

Brain Behav Immun. 2012 Jan;26(1):159-69. doi: 10.1016/j.bbi.2011.09.002. Epub 2011 Sep 8.

PMID:
21925261
6.

Methodological constraints in interpreting serum paraoxonase-1 activity measurements: an example from a study in HIV-infected patients.

Parra S, Marsillach J, Aragonès G, Rull A, Beltrán-Debón R, Alonso-Villaverde C, Joven J, Camps J.

Lipids Health Dis. 2010 Mar 25;9:32. doi: 10.1186/1476-511X-9-32.

7.
8.
9.

Identification and isolation of a 155-kDa protein with neuropathy target esterase activity.

Mackay CE, Hammock BD, Wilson BW.

Fundam Appl Toxicol. 1996 Mar;30(1):23-30.

PMID:
8812209

Supplemental Content

Loading ...
Support Center